Literature DB >> 21959306

Curcumin nanoformulations: a future nanomedicine for cancer.

Murali M Yallapu1, Meena Jaggi, Subhash C Chauhan.   

Abstract

Curcumin, a natural diphenolic compound derived from turmeric Curcuma longa, has proven to be a modulator of intracellular signaling pathways that control cancer cell growth, inflammation, invasion and apoptosis, revealing its anticancer potential. In this review, we focus on the design and development of nanoparticles, self-assemblies, nanogels, liposomes and complex fabrication for sustained and efficient curcumin delivery. We also discuss the anticancer applications and clinical benefits of nanocurcumin formulations. Only a few novel multifunctional and composite nanosystem strategies offer simultaneous therapy as well as imaging characteristics. We also summarize the challenges to developing curcumin delivery platforms and up-to-date solutions for improving curcumin bioavailability and anticancer potential for therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959306      PMCID: PMC3259195          DOI: 10.1016/j.drudis.2011.09.009

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  87 in total

1.  Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer.

Authors:  Yan Gao; Zhonggang Li; Min Sun; Houli Li; Chenyu Guo; Jing Cui; Aiguo Li; Fengliang Cao; Yanwei Xi; Hongxiang Lou; Guangxi Zhai
Journal:  Drug Dev Ind Pharm       Date:  2010-10       Impact factor: 3.225

2.  Design and development of water-soluble curcumin conjugates as potential anticancer agents.

Authors:  Ahmad Safavy; Kevin P Raisch; Sushma Mantena; Leisa L Sanford; Simon W Sham; N Rama Krishna; James A Bonner
Journal:  J Med Chem       Date:  2007-11-01       Impact factor: 7.446

3.  Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.

Authors:  Anindita Mukerjee; Jamboor K Vishwanatha
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

4.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

5.  Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems.

Authors:  H H Tønnesen; H de Vries; J Karlsen; G Beijersbergen van Henegouwen
Journal:  J Pharm Sci       Date:  1987-05       Impact factor: 3.534

6.  Polyamine conjugation of curcumin analogues toward the discovery of mitochondria-directed neuroprotective agents.

Authors:  Elena Simoni; Christian Bergamini; Romana Fato; Andrea Tarozzi; Sandip Bains; Roberto Motterlini; Andrea Cavalli; Maria Laura Bolognesi; Anna Minarini; Patrizia Hrelia; Giorgio Lenaz; Michela Rosini; Carlo Melchiorre
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

7.  Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines.

Authors:  Maria Pandelidou; Konstantinos Dimas; Aristidis Georgopoulos; Sophia Hatziantoniou; Costas Demetzos
Journal:  J Nanosci Nanotechnol       Date:  2011-02

8.  Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.

Authors:  Srinivas Ganta; Harikrishna Devalapally; Mansoor Amiji
Journal:  J Pharm Sci       Date:  2010-11       Impact factor: 3.534

Review 9.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 10.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

View more
  118 in total

Review 1.  Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.

Authors:  Elham Hatami; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-05-31       Impact factor: 10.680

Review 2.  Bioavailability enhancers of herbal origin: an overview.

Authors:  Kritika Kesarwani; Rajiv Gupta; Alok Mukerjee
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

Review 3.  Phytotherapy and Nutritional Supplements on Breast Cancer.

Authors:  C M Lopes; A Dourado; R Oliveira
Journal:  Biomed Res Int       Date:  2017-08-06       Impact factor: 3.411

4.  HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy.

Authors:  Zahra Matloubi; Zuhair Hassan
Journal:  Daru       Date:  2020-04-08       Impact factor: 3.117

5.  Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles.

Authors:  Chinmay G Hiremath; Geetha B Heggnnavar; Mahadevappa Y Kariduraganavar; Murigendra B Hiremath
Journal:  Prog Biomater       Date:  2019-06-13

6.  Pluronic micelles encapsulated curcumin manifests apoptotic cell death and inhibits pro-inflammatory cytokines in human breast adenocarcinoma cells.

Authors:  Foram U Vaidya; Rakesh Sharma; Sofiya Shaikh; Debes Ray; Vinod K Aswal; Chandramani Pathak
Journal:  Cancer Rep (Hoboken)       Date:  2018-09-24

Review 7.  Therapeutic actions of curcumin in bone disorders.

Authors:  Ramin Rohanizadeh; Yi Deng; Elise Verron
Journal:  Bonekey Rep       Date:  2016-03-02

8.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

9.  Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment.

Authors:  Murali M Yallapu; Mara C Ebeling; Sheema Khan; Vasudha Sundram; Neeraj Chauhan; Brij K Gupta; Susan E Puumala; Meena Jaggi; Subhash C Chauhan
Journal:  Mol Cancer Ther       Date:  2013-05-23       Impact factor: 6.261

Review 10.  Therapeutic Applications of Curcumin Nanoformulations.

Authors:  Murali M Yallapu; Prashanth K Bhusetty Nagesh; Meena Jaggi; Subhash C Chauhan
Journal:  AAPS J       Date:  2015-09-03       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.